A client with community-acquired bacterial pneumonia has an oral lefamulin prescription. The medication list includes pimozide, and the ECG shows a prolonged QT interval. Which action should the nurse take?
1Give both medicines and obtain another ECG after the antibiotic course is completed.
2Give a reduced lefamulin dose and reassess the QT interval after several doses.
3Hold oral lefamulin and notify the prescriber about the interacting regimen and QT finding.✓ Correct answer
4Switch to crushed tablets and separate the two medicines by at least four hours.
Explanation
Oral lefamulin is contraindicated with sensitive CYP3A4 substrates that prolong the QT interval because substrate exposure can rise and lead to torsades de pointes. Existing QT prolongation adds urgency to clarification.
Quick answer Hold and clarify oral lefamulin with pimozide and prolonged QT.
Why this is correct Changing the tablet form or adding a dose does not remove the pharmacokinetic and electrophysiologic risk. The interacting regimen requires prescriber and pharmacist review before administration.
Easy analogy or mental picture Build a medication-safety chain: identify the changing cue, connect it to the labeled toxicity or interaction, interrupt preventable exposure, stabilize the client, and verify a measurable response.
NCLEX decision rule Choose the action that prevents the most immediate medication-related harm while preserving indicated treatment and required monitoring.
Why the other choices are wrong Options that continue a suspect exposure, normalize a labeled danger cue, or delay escalation leave the client at risk.
References
1DailyMed: XENLETA (lefamulin)QT prolongation, contraindicated oral coadministration with QT-prolonging sensitive CYP3A4 substrates, and ECG/electrolyte risk review
Oncology medication-safety reviewVerify indication, current assessment, laboratory and oxygen trends, interactions, urgent toxicity cues, authorized action, and measurable follow-up.